{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:18:17Z","timestamp":1793661497226,"version":"4.5.1"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Parasitol."],"abstract":"<jats:p>\n                    Schistosomiasis is a group of both acute and chronic parasitic trematode infections of the genus\n                    <jats:italic>Schistosoma<\/jats:italic>\n                    . Research into schistosomiasis has been minimal, leading to its classification as a neglected tropical disease, yet more than 140 million people are infected with schistosomes globally. There are no treatments available for early-stage infections, schistosomal dermatitis, or Katayama syndrome, other than symptomatic control with steroids and antihistamines, as the maturing organisms seem to be mostly resistant to typical antiparasitics. However, praziquantel (PZQ) has been the drug of choice for schistosomiasis for decades in the latter stages of the disease. Though it is effective against all three clinically relevant species, heavy reliance on PZQ has led to concerns of schistosome resistance, especially in areas that have implemented this drug in mass drug administration (MDA) programs. This article summarizes the available literature concerning the available evidence for and against a warranted concern for PZQ resistance, genomic studies in schistosomes, proposed mechanisms of resistance, and future research in alternative methods of schistosomiasis treatment.\n                  <\/jats:p>","DOI":"10.3389\/fpara.2024.1471451","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:52:16Z","timestamp":1727830336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Praziquantel resistance in schistosomes: a brief report"],"prefix":"10.3389","volume":"3","author":[{"given":"Gabriela","family":"Eastham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane","family":"Fausnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.it.2022.06.005","article-title":"Type 2 immunity: a two-edged sword in schistosomiasis immunopathology","volume":"43","author":"Abdel Aziz","year":"2022","journal-title":"Trends. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/20477724.2022.2145070","article-title":"Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review","volume":"117","author":"Aboagye","year":"2023","journal-title":"Pathog. Glob. Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4269\/ajtmh.2006.74.342","article-title":"Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection","volume":"74","author":"Alonso","year":"2006","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1080\/14756366.2022.2078970","article-title":"Development of Praziquantel sulphonamide derivatives as antischistosomal drugs","volume":"37","author":"Angeli","year":"2022","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1038\/s41467-021-24958-0","article-title":"Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration","volume":"12","author":"Berger","year":"2021","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ijpara.2005.02.005","article-title":"Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt","volume":"35","author":"Botros","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-3024.2009.01098.x","article-title":"Immunopathogenesis of human schistosomiasis","volume":"31","author":"Burke","year":"2009","journal-title":"Parasite. Immunol."},{"key":"B8","volume-title":"Tropical medicine: A clinical text","author":"Cahill","year":"2011"},{"key":"B9","unstructured":"Schistosomiasis2024"},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever","volume":"195","author":"Cioli","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41588-018-0262-1","article-title":"Comparative genomics of the major parasitic worms","volume":"51","author":"Coghlan","year":"2019","journal-title":"Nat. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0169-4758(97)89815-8","article-title":"Defining resistance in schistosoma","volume":"13","author":"Coles","year":"1997","journal-title":"Parasitol. Today"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pt.2022.02.006","article-title":"A genetic TRP down the channel to praziquantel resistance","volume":"38","author":"Cotton","year":"2022","journal-title":"Trends. Parasitol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0074-02762011000200006","article-title":"Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails","volume":"106","author":"Couto","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/cid\/ciw506","article-title":"Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration","volume":"63","author":"Crellen","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1471-4922(01)02209-7","article-title":"Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal","volume":"18","author":"Danso-Appiah","year":"2002","journal-title":"Trends. Parasitol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1590\/s0074-02762005000400018","article-title":"Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa","volume":"100","author":"da Silva","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011236","article-title":"A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area","volume":"17","author":"Diemert","year":"2023","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/qco.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"Doenhoff","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pt.2019.01.004","article-title":"Genome-wide approaches to investigate anthelmintic resistance","volume":"35","author":"Doyle","year":"2019","journal-title":"Trends. Parasitol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/imcb.12229","article-title":"The anthelmintic drug praziquantel promotes human Tr1 differentiation","volume":"97","author":"Eyoh","year":"2019","journal-title":"Immunol. Cell. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1368-7646(98)80004-6","article-title":"Schistosome resistance to praziquantel","volume":"1","author":"Fallon","year":"1998","journal-title":"Drug Resist. Update"},{"key":"B24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s13071-019-3860-6","article-title":"Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda","volume":"12","author":"Faust","year":"2019","journal-title":"Parasitol. Vectors"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00095","article-title":"Eliminating schistosomes through vaccination: what are the best immune weapons","volume":"6","author":"Fonseca","year":"2015","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009189","article-title":"Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy","volume":"15","author":"Fukushige","year":"2021","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0169-4758(97)01024-7","article-title":"Anthelmintic resistance in human helminths: Learning from the problems with worm control in livestock","volume":"13","author":"Geerts","year":"1997","journal-title":"Parasitol. Today"},{"key":"B28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s13071-017-2533-6","article-title":"Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme","volume":"10","author":"Gower","year":"2017","journal-title":"Parasitol. Vectors"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1017\/S0031182013000231","article-title":"New approaches for understanding mechanisms of drug resistance in schistosomes","volume":"140","author":"Greenberg","year":"2013","journal-title":"Parasitology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"Gryseels","year":"2006","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/clinids\/20.2.309","article-title":"Persistence of schistosoma haematobium infection despite multiple courses of therapy with praziquantel","volume":"20","author":"Herwaldt","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.4155\/fmc.15.22","article-title":"Toward organometallic antischistosomal drug candidates","volume":"7","author":"Hess","year":"2015","journal-title":"Future. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8030170","article-title":"Human schistosomiasis vaccines as next generation control tools","volume":"8","author":"Hotez","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","article-title":"Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers","volume":"60","author":"Ismail","year":"1999","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1996.55.214","article-title":"Characterization of isolates of schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel","volume":"55","author":"Ismail","year":"1996","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B36","first-page":"685","article-title":"Laboratory induced resistance to praziquantel in experimental schistosomiasis","volume":"24","author":"Ismail","year":"1994","journal-title":"J. Egypt. Soc Parasitol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1096\/fj.09-137091","article-title":"Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel","volume":"24","author":"Kasinathan","year":"2010","journal-title":"FASEB. J."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj9114","article-title":"Genetic analysis of praziquantel response in schistosome parasites implicates a transient receptor potential channel","volume":"13","author":"Le Clec\u2019h","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.29261\/pakvetj\/2023.062","article-title":"Studies on resistance of Schistosoma to praziquantel XIV. Experimental comparison of susceptibility to praziquantel between praziquantel-resistant isolates and praziquantel-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia, and cercariae","volume":"23","author":"Li","year":"2011","journal-title":"Chin. J. Schistosomiasis. Control."},{"key":"B40","first-page":"824","article-title":"Drug resistance and genetic relatedness of Escherichia coli from mink in Northeast China","volume":"43","author":"Li","year":"2023","journal-title":"Pak. Vet. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-3156.2001.00772.x","article-title":"Susceptibility of Schistosoma japonicum to praziquantel in China","volume":"6","author":"Liang","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3109\/13880209.2014.970289","article-title":"Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni","volume":"53","author":"Lotfy","year":"2015","journal-title":"Pharm. Biol."},{"key":"B43","first-page":"383","article-title":"Molecular characterization of antibiotic resistance in poultry gut origin enterococci and horizontal gene transfer of antibiotic resistance to Staphylococcus aureus","volume":"42","author":"Malik","year":"2022","journal-title":"Pak. Vet. J."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008388","article-title":"Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe","volume":"14","author":"Mduluza","year":"2020","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000504","article-title":"Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni","volume":"3","author":"Melman","year":"2009","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.25761\/anaisihmt.189","article-title":"Genetic analysis of Schistosoma mansoni sensitive and resistant strains to praziquantel using RAPD-PCR","volume":"12","author":"Mendes","year":"2018","journal-title":"An. Inst. Hig. Med. Trop. Lisb."},{"key":"B47","doi-asserted-by":"publisher","first-page":"539","DOI":"10.47278\/journal.ijvs\/2021.127","article-title":"Current status of multidrug resistance of Ornithobacterium rhinotracheale from avian host","volume":"11","author":"Mohamed","year":"2022","journal-title":"Int. J. Vet. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-020-0621-y","article-title":"Schistosomiasis vaccine development: update on human clinical trials","volume":"27","author":"Molehin","year":"2020","journal-title":"J. BioMed. Sci."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2022.111531","article-title":"Praziquantel: An update on the mechanism of its action against schistosomiasis and new therapeutic perspectives","volume":"252","author":"Nogueira","year":"2022","journal-title":"Mol. Biochem. Parasitol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4269\/ajtmh.2010.10-0283","article-title":"Genetic consequences of mass human chemotherapy for schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania","volume":"83","author":"Norton","year":"2010","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pt.2019.11.002","article-title":"The journey to discovering a flatworm target of praziquantel: A long TRP","volume":"36","author":"Park","year":"2020","journal-title":"Trends. Parasitol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"Pica-Mattoccia","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1751-0813.1980.tb15983.x","article-title":"The problem of anthelmintic resistance in nematodes","volume":"56","author":"Prichard","year":"1980","journal-title":"Aust. Vet. J."},{"key":"B54","first-page":"376","article-title":"Anthelmintic Resistance in Haemonchus contortus of sheep and goats from Asia\u2013a review of in vitro and in vivo studies","volume":"43","author":"Qamar","year":"2023","journal-title":"Pak. Vet. J."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104727","article-title":"Population genetics of African Schistosoma species","volume":"89","author":"Rey","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/00034983.1989.11812373","article-title":"Effect of praziquantel on the eggs of Schistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasis","volume":"83","author":"Richards","year":"1989","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"B57","unstructured":"Praziquantel2024"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10101724","article-title":"Development of the sm14\/GLA-SE schistosomiasis vaccine candidate: an open, non-placebo-controlled, standardized-dose immunization phase ib clinical trial targeting healthy young women","volume":"10","author":"Santini-Oliveira","year":"2022","journal-title":"Vaccines"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0542","article-title":"Human schistosomiasis resistance to praziquantel in China: Should we be worried","volume":"85","author":"Seto","year":"2011","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1086\/517273","article-title":"Oxamniquine cures schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low","volume":"176","author":"Stelma","year":"1997","journal-title":"J. Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4269\/ajtmh.1995.53.167","article-title":"Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni","volume":"53","author":"Stelma","year":"1995","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2022.933097","article-title":"A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: Is praziquantel and intestinal schistosomiasis a perfect match","volume":"3","author":"Summers","year":"2022","journal-title":"Front. Trop. Dis."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/medsci8010010","article-title":"Persistent urogenital schistosomiasis and its associated morbidity in endemic communities within southern Ghana: suspected praziquantel resistance or reinfection","volume":"8","author":"Tetteh-Quarcoo","year":"2020","journal-title":"Med. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1365-3156.2000.00646.x","article-title":"Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection","volume":"5","author":"Utzinger","year":"2000","journal-title":"Trop. Med. Int. Health"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e02582","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B66","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/14656566.2024.2333372","article-title":"Current drug strategies for the treatment and control of schistosomiasis","volume":"25","author":"Villamizar-Monsalve","year":"2024","journal-title":"Expert. Opin. Pharmacother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"Wang","year":"2012","journal-title":"Parasitol. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijpara.2004.04.005","article-title":"Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca 2+-uptake as possible in vitro correlates to in vivo ED 50 determination","volume":"34","author":"William","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S0031182000007137","article-title":"Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections","volume":"122","author":"William","year":"2001","journal-title":"Parasitology"},{"key":"B70","unstructured":"Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021\u20132030GenevaWorld Health Organization2020"},{"key":"B71","unstructured":"Schistosomiasis and soil-transmitted helminthiases: progress report2021"},{"key":"B72","volume-title":"WHO guideline on control and elimination of schistosomiasis","year":"2022"},{"key":"B73","unstructured":"Schistosomiasis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis2023"},{"key":"B74","volume-title":"34th meeting of the international task force for disease eradication, 19-20 september 2022","year":"2023"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00436-011-2670-3","article-title":"New insight into praziquantel against various developmental stages of schistosomes","volume":"109","author":"Wu","year":"2011","journal-title":"Parasitol. Res."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011215","article-title":"Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica","volume":"17","author":"Xu","year":"2023","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0035-9203(01)90032-X","article-title":"Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China","volume":"95","author":"Yu","year":"2001","journal-title":"Trans. R. Soc Trop. Med. Hyg"},{"key":"B78","first-page":"85","article-title":"Failure to induce resistance of Schistosoma japonicum to praziquantel","volume":"21","author":"Yue","year":"1990","journal-title":"Southeast. Asian. J. Trop. Med. Public. Health"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008649","article-title":"Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models","volume":"14","author":"Zdesenko","year":"2020","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01246","article-title":"Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Parasitology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpara.2024.1471451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:52:20Z","timestamp":1727830340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpara.2024.1471451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":80,"alternative-id":["10.3389\/fpara.2024.1471451"],"URL":"https:\/\/doi.org\/10.3389\/fpara.2024.1471451","relation":{},"ISSN":["2813-2424"],"issn-type":[{"value":"2813-2424","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"article-number":"1471451"}}